The 28th Annual Enterprise Awards

Our region's most prestigious celebration of achievement, innovation, and success for leaders in life sciences and technology. Now a two-night event, featuring an in-person celebration June 29, and the online broadcast of the Enterprise Awards ceremony June 30.

Celebrate Our Innovators!

The 2021 Enterprise Awards will be a two-night, hybrid event featuring an in-person celebration on 6/29 and an online broadcast of the Enterprise Awards ceremony on 6/30, presented by Fairmount Partners and KPMG.

  • The 2021 Enterprise Awards Celebration – June 29th – In-Person

    6:00 PM to 9:00 PM

    Join our nominees and VIP guests at this
    outdoor, tented event on the Tavola Patio at Springfield Country
    Club from 6:00 to 9:00 pm. Enjoy al fresco cocktails and tasting
    plates as you reconnect with colleagues and meet our 2021
    honorees – plus a special in-person recognition of this year’s
    Legend Award Honoree for lifetime achievement, Josh Kopelman.

    New Dress Code – Smart Casual for a Summer Evening – no ties,
    gowns or tuxes!

  • The 28th Annual Enterprise Awards Ceremony Broadcast – June 30th – Virtual

    4:30 PM to 5:45 PM

    VIRTUAL: The 28th Annual Enterprise Awards Ceremony Broadcast will take place from 4:30pm – 5:45pm, where we will announce all of our winners.

View the Digital Tribute Journal: Open Journal

Read the press release: PACT Announces Hybrid Format for 2021 Enterprise Awards

Watch the Official Finalist Announcement: 28th Annual Enterprise Awards Finalists Announcement

 

Did you miss the Enterprise Awards Broadcast?

Celebrate Our Innovators!

AWARD CRITERIA

About the 2022 Enterprise Awards Categories

To View the Enterprise Awards Applications, please click on each award heading below.

Nomination Form »

Title Sponsor: Fairmount Partners

Judging Partner: KPMG LLP

Technology Startup

Sponsors: Troutman Pepper

Criteria:

  • Company must have been in operation at some point in the period between January 1, 2018 and December 31, 2021.

Key Considerations:

  • Product or service innovation including market need or assessment.
  • Potential for significant growth.
  • The management team and its ability and record of achieving success.
  • A demonstration of success such as significant milestones, raising capital, and revenue.

Technology Emerging

Sponsors: Fox Rothschild LLP

Criteria:

  • Company must have been in operation before January 1, 2018. Revenues must be less than $50 million, except in the most recent fiscal year.

Key Considerations:

  • Product or service innovation, including proprietary technology or other advantage.
  • Company milestones including strategic decisions made by management that led to growth in revenues and/or earnings.
  • Strength of management team including ability to raise capital.
  • Profitability or demonstrated ability to achieve profitability (e.g. strategy to achieve break even, the ability to realize high gross margins, etc.), and decisions that led to corporate collaborations or license deals.

Technology CEO

Sponsor: Cozen O’Connor

Criteria:

  • Individual’s background (CV/Bio required) and the company’s success to date.

Key Considerations:

  • CEO’s management accomplishments and philosophy, including the communication of a vision and goals as achieved by the company.
  • Leadership and impact in industry and/or market.
  • Ability to attract and retain talent.
  • Company milestones including financial accomplishments and a strategy for continued company success.
  • Community and/or industry involvement.
  • Extra consideration is given to leaders who have contributed more broadly to the strengthening and promotion of the tech industry in the region.

Technology Company

Sponsor: Comcast Business

Criteria:

  • Company with more than $50 million in revenues in the most recently completed fiscal year.

Key Considerations:

  • Leadership and product and/or service innovation in an industry or market.
  • Significant company milestones including financial accomplishments.
  • Community and industry involvement.

Investment Deal

Sponsor: EPAM and Baker Tilly

Criteria:

  • Deal must have been fully executed between January 1, 2021 and December 31, 2021.
  • Events that qualify for this category include Exit Transaction (e.g. IPO), Capital Raising Transaction (e.g. financing: debt, mezzanine, equity; recap), Buy-side or Sell-side of a Merger & Acquisition Transaction.

Key Considerations:

Entries must include a Business and Transaction Narrative/Summary.

  • Brief history and/or background of the deal.
  • Key deal stats (transaction size, valuation, valuation multiple, value to shareholders).
  • Strategic considerations of the deal (e.g. commercial strategy, innovation, and contribution to market development.
  • How did the sale or purchase impact the broader industry(s) of the buyer and/or seller?
  • Provide a brief business description including offerings, first-mover advantages, competitive barriers, and any unique asset(s), IP, technology, etc.
  • Provide a brief history of business from its inception – especially as it relates to results from invested capital (if transaction was a sale).
  • What amount was invested from the inception and its uses. How much was invested in unique technology or other assets?

Life Sciences & Healthcare Startup

Sponsor: Ben Franklin Technology Partners

Criteria:

  • Company must have been in operation at some point in the period between January 1, 2018 and December 31, 2021.

Key Considerations:

  • Discuss product innovation including market need/assessment and potential for significant growth.
  • Discuss the management team and its ability and record of achieving success.
  • Provide demonstration of success (e.g., significant milestones, raising capital, revenue, etc.).
  • Describe the R&D investment strategy.
  • What did the company do to overcome challenges in financing, development or commercialization?

Life Sciences & Healthcare Emerging

Sponsor: RSM US LLP and SAP

Criteria:

  • Company must have been in operation before January 1, 2018. Must have sales, grants, or licensing fees. The Company should have no more than 3 years of operating results since its founding.

Key Considerations:

  • Describe product, including proprietary applications or other advantage.
  • What animal or OUS (outside of the United States) clinical work has been done to prove the technology?
  • Describe the impact on the clinical problem this technology is trying to solve (e.g. saving a hospital money on a procedure, making a clinician more productive, etc.).
  • Address the strength of the management team including ability to raise capital.
  • Profitability or demonstrated ability to achieve profitability (e.g., strategy to achieve break even, ability to realize high gross margins, etc.) or decisions that led to corporate collaborations or license deals.

Life Sciences & Healthcare CEO

Sponsors: EY and Morgan Lewis

Criteria:

  • Individual’s background (CV/Bio required) and the company’s success to date.

Key Considerations:

  • Describe CEO’s management accomplishments and philosophy, including the communication of a vision and goals as achieved by the company.
  • Leadership and impact in industry and/or market.
  • Ability to attract and retain talented resources.
  • Company milestones including financial accomplishments and a strategy for continued company success.
  • Community/industry involvement.
  • Extra consideration is given to leaders who have contributed more broadly to the strengthening and promotion of the life sciences/healthcare industry in the region.

Life Sciences & Healthcare Company

Criteria:

  • Company must have at least four years of operating results in industry segments such as specialty pharmaceuticals, biotechnology, medicaldevices/instrumentation, therapeutics and diagnostics.

Key Considerations:

  • Compnay should demonstrate its ability to raise capital; generate revenue; and commercialization and/or strategy to enter into substantive strategic alliances.
  • Company should demonstrate its development strategy and clinical pathway to development.
  • Describe any significant events, e.g. product discovery, drug registration, an exit, an increase in sales etc. that occurred in 2021.
  • What did the company do to overcome challenges in financing, development, or commercialization?

Healthcare Innovator

Sponsor: Independence Blue Cross

Criteria:

  • The nominee can be a company, researcher, investor, or individual providing an innovative solution that has the potential to make a large and positive impact on cost, quality, and/or access in health care.

Key Considerations:

  • The nominee should have a demonstrated business model for its solution and demonstrate the ability to generate rapid growth.
  • The nominee should be able to demonstrate return on investment or clinical impact of its solution.
  • The nominee can be in any sector (technology, life sciences, investment, health care delivery, etc.), but must be serving the healthcare industry in Greater Philadelphia.
  • The nominee must demonstrate creativity and passion to re-thinking healthcare in the region and to driving exceptional health outcomes or dramatically lowering costs.

Legend Award (Lifetime Achievement)

Sponsor: Cigniti Technologies and Grant Thornton LLP

The Legend Award for Lifetime Achievement is presented to an individual who has forwarded technology and sciences in the region through leadership and exemplary work. The Legend recipient must have a strong connection to the community, a history of personal accomplishments and a track record of success.

Tribute Journal

Enterprise Awards Tribute Journal

The Tribute Journal will provide you with more information on each award, finalists, sponsors and tributes. It is an ideal opportunity to recognize our honorees and finalists at the Enterprise Awards by honoring them in the context of a memorable message.


    Choose a full-page message featured in the Tribute Journal - $1,600Choose a half-page message featured in the Tribute Journal - $1,200

    View the 2021 Tribute Journal »
    A dynamic digital Tribute Journal is available to all guests of the Enterprise Awards.

    Information

    For more information, please contact Dianne Strunk.

    Watch with Us

    CLICK HERE to watch the 28th Annual Enterprise Awards.

    JUDGES

    2022 Enterprise Awards Judges

    Judging Partner – KPMG

    Presiding Judge – Technology: Andrew Cherry, Partner, KPMG

    Presiding Judges – Life Sciences & Healthcare: Tom Koncsics, Partner, KPMG with Jennifer Strong, Partner, KPMG

    Lead Judge: Rick Riegel, Chairman, ActiGraph and Deerfield

    Technology Judges

    • Jared Blitzstein
      Director of Software Engineering
      Boomi
    • Greg Doran  
      CFO
      Frontline Education
    • Sean Dowling
      Partner
      Osage Venture Partners
    • Shintaro Kaido
      Vice Provost for Innovation & Executive Director, Drexel Applied Innovation
      Drexel University
    • Brian Kim
      Partner
      NewSpring Capital
    • Kalyana Rao Konda
      President, NA East
      Cigniti Technologies
    • Brian McCabe
      Senior Director, Technology Finance
      BridgeBank
    • Dan Klein
      Managing Director
      Slalom
    • Nihan Rahman
      Managing Director
      Instamed, a JP Morgan Company
    • Nassar Nizami
      CIO
      Jefferson University/Einstein
    • Debbie O’Brien
      SVP, Market Manager
      Bank of America
    • Pooja Ojala
      Vice President, Strategy
      Veeva
    • Daphne Thomas
      COO
      iPipeline
    • April Walker
      Sr. Director,
      US Microsoft Technology Centers

    Life Sciences & Healthcare Judges

    • Kevin Brophy
      Life Sciences Industry Principal
      SAP
    • Carol Burnes
      CEO
      Cagent Vascular
    • Greg Cathcart 
      CEO 
      Excellis Health Solutions
    • Victor Caraballo
      Vice President Quality Management
      Independence Blue Cross
    • Gerianne DiPiano
      CEO
      FemmePharma
    • Lawana Dumas
      Director, Oncology Strategic Alliances
      Merck
    • Lalo Flores
      CEO
      Century Therapeutics
    • Shahram Hejazi
      Managing Director and CEO
      BioAdvance
    • Dr. Calvin Knowlton
      CEO, Chairman & Founder
      Tabula Rasa
    • Maria Maccecchini
      CEO
      Annovis Bio
    • Matthew Reber
      Partner
      1315 Capital
    • Heather Steinman
      VP, Business Development and Executive Director of Technology Transfer
      The Wistar Institute
    • Zev Sunleaf
      Vice President, Office of Technology Transfer, Commercialization & Innovation
      Children’s Hospital of Philadelphia

    SPONSORS

    Enterprise Awards Sponsors

    For more information, please contact Dianne Strunk.

    Title Partner

    Judging Sponsor

    Broadcast Sponsor

    Competitive Award Sponsors

    Event Sponsors

    Enterprise Sponsors

    FINALISTS

    2021 Enterprise Awards Finalists

    • Life Sciences & Healthcare Startup
      • Avisi Technologies
      • Envara Health
      • The Discovery Labs

    Sponsor:  Ben Franklin Technology Partners

    • Technology Startup
      • Crossbeam
      • Grovara
      • PatientWing

    Sponsors:  Troutman Pepper

    • Investment Deal
      • Passage Bio
      • TrialScope
      • Vertex

    Sponsors:  Baker Tilly and EPAM

    • Life Sciences & Healthcare Emerging
      • Antares Pharma
      • Incyte
      • Myonex

    Sponsor:  RSM and SAP

    • Technology Emerging
      • Greenphire
      • Infinite Blue
      • IntegriChain

    Sponsor:  EisnerAmper and Fox Rothschild

    • Life Sciences & Healthcare CEO
      • Annovis Bio, Maria Maccecchini, PhD
      • Astarte Medical, Tracy Warren
      • MOBILion Systems, Melissa Sherman, PhD

    Sponsor: EY and Morgan Lewis & Bockius

    • Technology CEO
      • iPipeline, Larry Berran
      • Frontline Education, Mark Gruzin
      • Odessa, Madhu Natarajan

    Sponsors:  Cozen O’Connor

    • Healthcare Innovator
      • AnaOno
      • Genomind
      • NeuroFlow

    Sponsor:  Independence Blue Cross

    • Technology Company
      •  AGI, An Ansys Company
      • Relay Network
      • Suvoda

    Sponsor:  Comcast Business

    Honoree

    2021 Legend Award Honoree

    Sponsored by: Cigniti Technologies and Grant Thornton

    Josh Kopelman

    First Round Capital

    Josh Kopelman

    Josh is Founding Partner of First Round Capital, one of the leading seed-stage venture funds in the country, including 25 investments in local companies. Josh has consistently ranked in the top 20 of Forbes annual “Midas List” of the top 100 tech investors. Before becoming a venture capitalist, Josh founded three companies: In 1992 Josh co-founded Infonautics Corporation – taking it public in 1996. Josh co-founded Half.com in 1999 and led the company through its acquisition by eBay. And in 2003 Josh helped to found TurnTide, an anti-spam company that was acquired by Symantec. Josh is an inventor on over a dozen U.S. Patents for his work in Internet technology. On a local level, Josh also serves as Chairman of the Board for The Philadelphia Inquirer, LLC and is a member of the board of directors of the Ed Snider Youth Hockey Foundation.

    WINNERS

    Enterprise Awards 2021 Winners

     

     

    2021

    WINNER

    CATEGORY

     

    Crossbeam

    Technology Startup

    Envara Health

    Life Sciences & Healthcare Startup

    Greenphire

    Technology Emerging

    Incyte

    Life Sciences & Healthcare Emerging

    Vertex

    Investment Deal

    Larry Berran, iPipeline

    Technology CEO

    Maria Maccecchini, Annovis Bio

    Life Sciences & Healthcare CEO

    Suvoda

    Technology Company

    Neuroflow

    Healthcare Innovator

     

    NOMINATION FORM

    2022 Enterprise Awards Nomination Form

    The Enterprise Awards, presented by Fairmount Partners and KPMG LLP, recognize and honor leadership and outstanding achievement in the technology, healthcare and life science industries throughout the region. Nominations for 2022 are now open.

    Nomination Form


    ©2020 PACT All Rights Reserved